Skip to main content
. 2022 Aug 27;11(17):2666. doi: 10.3390/cells11172666

Figure 4.

Figure 4

A. muciniphila administration increases IL22 and IL17 without affecting other markers of inflammation, gut barrier, cell renewal, proliferation markers, and matrix formation. Relative mRNA expression of markers of (A) inflammation, (B) gut barrier integrity, (C) cell renewal, proliferation, and differentiation, (D) extracellular matrix at the site of perforation. Data are shown as mean ± SEM, black dots (dotplots) represent individual values for each animal; * p-values were obtained after non-parametric Mann–Whitney test.